Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder

NCT00135421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Pexacerfont
DRUG: Escitalopram
DRUG: Placebo

Sponsor

Bristol-Myers Squibb